RESUMO
Lymphoma is the most common hematopoietic tumour in dogs and is remarkably similar to the human disease. Tumour biomarker discovery is providing new tools for diagnostics and predicting therapeutic response and clinical outcome. MicroRNAs are small non-coding RNAs that participate in post-transcriptional gene regulation and their aberrant expression can impact genes involved in cancer. The aim of this study was to characterize microRNA expression in lymph nodes and plasma from dogs with multicentric B or T cell lymphoma compared to healthy control dogs. We further compared expression between lymph nodes and corresponding plasma samples and assessed changes in expression at relapse compared to time of diagnosis. Lastly, we investigated microRNAs for association with clinical outcome in patients treated with CHOP chemotherapy. A customized PCR array was utilized to profile 38 canine target microRNAs. Quantification was performed using real time RT-qPCR and relative expression was determined by the delta-delta Ct method. In lymph nodes, there were 16 microRNAs with significantly altered expression for B cell lymphoma and 9 for T cell lymphoma. In plasma, there were 15 microRNAs altered for B cell lymphoma and 3 for T cell lymphoma. The majority of microRNAs did not have correlated expression between lymph node and plasma and only 8 microRNAs were significantly different between diagnosis and relapse. For B cell lymphoma, 8 microRNAs had differential expression in the non-remission group compared to dogs that completed CHOP in complete remission. Four of these microRNAs were also altered in patients that died prior to one-year. Kaplan-Meier survival curves for high versus low microRNA expression revealed that 10 microRNAs were correlated with progression-free survival and 3 with overall survival. This study highlights microRNAs of interest for canine multicentric lymphoma. Future goals include development of microRNA panels that may be useful as biomarkers with the intent to provide improved outcome prediction to veterinary cancer patients.
Assuntos
Doenças do Cão/diagnóstico , Linfoma de Células B/diagnóstico , Linfoma de Células T/diagnóstico , MicroRNAs/metabolismo , Animais , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Biomarcadores Tumorais/genética , Biomarcadores Tumorais/metabolismo , Ciclofosfamida/uso terapêutico , Doenças do Cão/tratamento farmacológico , Doenças do Cão/genética , Doenças do Cão/mortalidade , Cães , Doxorrubicina/uso terapêutico , Feminino , Regulação Neoplásica da Expressão Gênica , Imunofenotipagem , Estimativa de Kaplan-Meier , Linfonodos/metabolismo , Linfoma de Células B/tratamento farmacológico , Linfoma de Células B/genética , Linfoma de Células B/mortalidade , Linfoma de Células T/tratamento farmacológico , Linfoma de Células T/genética , Linfoma de Células T/mortalidade , Masculino , MicroRNAs/sangue , Recidiva Local de Neoplasia , Prednisona/uso terapêutico , Intervalo Livre de Progressão , Resultado do Tratamento , Vincristina/uso terapêuticoRESUMO
A dog with a history of recurrent pericardial effusion that required repeated pericardiocentesis was presented to the surgical service at the Ontario Veterinary College Health Sciences Centre for thoracoscopic pericardiectomy. Physical examination revealed a subcutaneous mass in the right lateral thorax. Cytology of the subcutaneous mass and histopathology of the pericardium were consistent with mesothelioma. This article details the first reported case of pericardial mesothelioma with suspected extra-thoracic metastasis following pericardiocentesis in a dog.
Implantation métastasique présumée d'un mésothéliome péricardique à la suite de péricardiocentèses répétées chez un chien. Un chien avec une historique d'effusions péricardiques récurrentes qui nécessitaient des péricardiocentèses répétées fut présenté au service de chirurgie du Ontario Veterinary College Health Sciences Centre pour une péricardiectomie thoracoscopique. L'examen physique a révélé une masse souscutanée dans le thorax latéral droit. L'examen cytologique de la masse sous-cutanée et l'histopathologie du péricarde étaient cohérents avec un mésothéliome. Le présent article donne les détails du premier cas rapporté chez un chien de mésothéliome péricardique avec métastase extra-thoracique suspectée consécutive à la suite de péricardiocentèses.(Traduit par Dr Serge Messier).
